Mark G. Kris1 article listing Mark G. Kris in Nature Communications, indexed by Paperzzz from Crossref and OSF.Canakinumab with chemoradiation and durvalumab consolidation in unresectable stage III non-small cell lung cancer: the phase I/II CHORUS trial Nature Communications